|
| 25/09/2002 |
ALIZYME COMPLETES PATIENT RECRUITMENT IN PHASE IIb CLINICAL TRIAL OF RENZAPRIDE IN IRRITABLE BOWEL SYNDROME |
|
| 13/09/2002 |
DIRECTORS' SHARE PURCHASES |
|
| 27/08/2002 |
ALIZYME PRESENTS PHASE Ib CLINICAL TRIAL RESULTS FOR |
|
| 25/07/2002 |
ALIZYME PLC INTERIM REPORT FOR THE SIX MONTHS ENDED 30 JUNE 2002 |
|
| 19/06/2002 |
ALIZYME GRANTED CTX FOR PHASE IIb CLINICAL TRIAL FOR ATL-962 FOR OBESITY |
|
| 21/05/2002 |
APPOINTMENTS OF NON EXECUTIVE DIRECTOR AND HEAD OF DEVELOPMENT OPERATIONS |
|
| 15/05/2002 |
ALIZYME PLC : THE ANNUAL GENERAL MEETING : 2002 |
|
| 15/05/2002 |
SUCCESSFUL COMPLETION OF PHASE Ib CLINICAL TRIAL AND NOTICE OF GRANT OF A EUROPEAN PATENT FOR ATL-104 IN MUCOSITIS |
|
| 11/04/2002 |
DIRECTORS' SHARE PURCHASES |
|
| 11/04/2002 |
FINANCIAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2001 |
|
| 11/04/2002 |
DIRECTOR'S SHARE OPTIONS |
|
| 11/04/2002 |
ALIZYME TO COMMENCE CLINICAL TRIAL FOR RENZAPRIDE IN IRRITABLE BOWEL SYNDROME PATIENTS IN USA |
|
| 27/03/2002 |
ALIZYME OBTAINS APPROVAL FOR PHASE Ib CLINICAL TRIAL OF ATL-104 IN MUCOSITIS |
|
| 14/02/2002 |
ALIZYME OBTAINS APPROVAL FOR PHASE III CLINICAL TRIAL OF COLAL-PRED™ IN MAINTENANCE OF REMISSION OF ULCERATIVE COLITIS |
|
| 14/02/2002 |
ALIZYME ANNOUNCES POSITIVE PHASE II CLINICAL TRIAL RESULTS FOR TREATMENT OF ULCERATIVE COLITIS WITH COLAL-PRED™ |
|
| 31/01/2002 |
ALIZYME GRANTED APPROVAL FOR A PHASE IIb STUDY OF ATL-1251 IN MIXED SYMPTOM IRRITABLE BOWEL SYNDROME PATIENTS |
|
| 17/01/2002 |
SUCCESSFUL COMPLETION OF PHASE Ia CLINICAL TRIAL OF MUCOSITIS DRUG ATL-104 |
|
Help